Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 135

1.

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation.

Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, Sinnaeve P, Camm AJ, Kirchhof P; European Heart Rhythm Association.

Europace. 2013 May;15(5):625-51. doi: 10.1093/europace/eut083.

PMID:
23625942
[PubMed - indexed for MEDLINE]
Free Article
2.

EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary.

Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, Sinnaeve P, Camm AJ, Kirchhof P.

Eur Heart J. 2013 Jul;34(27):2094-106. doi: 10.1093/eurheartj/eht134. Epub 2013 Apr 26.

PMID:
23625209
[PubMed - indexed for MEDLINE]
Free Article
3.

Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF).

Kirchhof P, Ammentorp B, Darius H, De Caterina R, Le Heuzey JY, Schilling RJ, Schmitt J, Zamorano JL.

Europace. 2014 Jan;16(1):6-14. doi: 10.1093/europace/eut263. Epub 2013 Oct 1.

PMID:
24084680
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis.

Lip GY, Andreotti F, Fauchier L, Huber K, Hylek E, Knight E, Lane DA, Levi M, Marin F, Palareti G, Kirchhof P; Document reviewers:, Collet JP, Rubboli A, Poli D, Camm J.

Europace. 2011 May;13(5):723-46. doi: 10.1093/europace/eur126.

PMID:
21515596
[PubMed - indexed for MEDLINE]
Free Article
5.

Which oral anticoagulant for which atrial fibrillation patient: recent clinical trials and evidence-based choices.

Cairns JA.

Can J Cardiol. 2013 Oct;29(10):1165-72. doi: 10.1016/j.cjca.2013.05.010. Epub 2013 Aug 7. Review.

PMID:
23932012
[PubMed - indexed for MEDLINE]
6.

Novel oral anticoagulants for atrial fibrillation.

Hankey GJ, Eikelboom JW.

Curr Atheroscler Rep. 2013 Aug;15(8):344. doi: 10.1007/s11883-013-0344-6. Review.

PMID:
23761015
[PubMed - indexed for MEDLINE]
7.

[Anticoagulant therapy for chronic cardiac diseases. Atrial fibrillation, valvular heart disease, congestive heart failure].

Witzenbichler B.

Internist (Berl). 2011 Nov;52(11):1301-2, 1304-6, 1308-9. doi: 10.1007/s00108-011-2838-z. Review. German.

PMID:
22012548
[PubMed - indexed for MEDLINE]
8.

Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation.

Huber K, Connolly SJ, Kher A, Christory F, Dan GA, Hatala R, Kiss RG, Meier B, Merkely B, Pieske B, Potpara T, Stępińska J, Klun NV, Vinereanu D, Widimský P.

Int J Clin Pract. 2013 Jun;67(6):516-26. doi: 10.1111/ijcp.12147. Epub 2013 Apr 5. Review.

PMID:
23557519
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.

Torn M, Cannegieter SC, Bollen WL, van der Meer FJ, van der Wall EE, Rosendaal FR.

Arch Intern Med. 2009 Jul 13;169(13):1203-9. doi: 10.1001/archinternmed.2009.176.

PMID:
19597069
[PubMed - indexed for MEDLINE]
10.

Management of acute coronary syndrome in patients with non-valvular atrial fibrillation: results of the European Heart Rhythm Association Survey.

Potpara TS, Lip GY, Dagres N, Estner HL, Larsen TB, Blomström-Lundqvist C; Conducted by the Scientific Initiatives Committee, European Heart Rhythm Association.

Europace. 2014 Feb;16(2):293-8. doi: 10.1093/europace/euu008.

PMID:
24478291
[PubMed - indexed for MEDLINE]
Free Article
11.

[Effective, safe stroke prevention with novel oral anticoagulants in patients with atrial fibrillation. Focus on dabigatran].

Szapary L, Fehér G, Bosnyák E, Deli G, Csécsei P.

Ideggyogy Sz. 2013 May 30;66(5-6):165-74. Review. Hungarian.

PMID:
23909016
[PubMed - indexed for MEDLINE]
12.

Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.

Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY.

Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7. Review.

PMID:
22684583
[PubMed - indexed for MEDLINE]
13.

Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.

Dentali F, Riva N, Crowther M, Turpie AG, Lip GY, Ageno W.

Circulation. 2012 Nov 13;126(20):2381-91. doi: 10.1161/CIRCULATIONAHA.112.115410. Epub 2012 Oct 15. Review.

PMID:
23071159
[PubMed - indexed for MEDLINE]
Free Article
14.

Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Singer DE, Albers GW, Dalen JE, Fang MC, Go AS, Halperin JL, Lip GY, Manning WJ; American College of Chest Physicians.

Chest. 2008 Jun;133(6 Suppl):546S-592S. doi: 10.1378/chest.08-0678.

PMID:
18574273
[PubMed - indexed for MEDLINE]
15.

[Expert consensus of the French society of geriatrics and gerontology and the French society of cardiology on the management of atrial fibrillation in elderly people].

Hanon O, Assayag P, Belmin J, Collet JP, Emeriau JP, Fauchier L, Forette F, Friocourt P, Gentric A, Leclercq C, Komajda M, Le Heuzey JY; French society of geriatrics and gerontology and the French society of cardiology.

Geriatr Psychol Neuropsychiatr Vieil. 2013 Jun;11(2):117-43. doi: 10.1684/pnv.2013.0407. French.

PMID:
23803629
[PubMed - indexed for MEDLINE]
16.

The place of newer oral anticoagulants in the treatment of patients with non-valvular atrial fibrillation and coronary artery disease.

McCormack T.

Int J Clin Pract. 2013 Aug;67(8):707-9. doi: 10.1111/ijcp.12165.

PMID:
23869674
[PubMed - indexed for MEDLINE]
17.

Novel oral anticoagulants in patients undergoing cardioversion for atrial fibrillation.

Briasoulis A, Kottam A, Khan M, Afonso L.

J Thromb Thrombolysis. 2014 Dec 27. [Epub ahead of print]

PMID:
25542262
[PubMed - as supplied by publisher]
18.

Treatment with novel oral anticoagulants: indications, efficacy and risks.

Ghanny S, Crowther M.

Curr Opin Hematol. 2013 Sep;20(5):430-6. doi: 10.1097/MOH.0b013e328363c170. Review.

PMID:
23852184
[PubMed - indexed for MEDLINE]
19.

Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants.

Liew A, Eikelboom JW, O'Donnell M, Hart RG.

Can J Cardiol. 2013 Jul;29(7 Suppl):S34-44. doi: 10.1016/j.cjca.2013.04.013. Review.

PMID:
23790596
[PubMed - indexed for MEDLINE]
20.

Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.

De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Verheugt FW, Weitz JI.

Thromb Haemost. 2013 Dec;110(6):1087-107. doi: 10.1160/TH13-06-0443. Epub 2013 Nov 14. Review.

PMID:
24226379
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk